USPTO serial 85183296
PURGENESIS TECHNOLOGIES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- KHAN, ASMAT A
- Law office
- TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PURGENESIS TECHNOLOGIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Montmagny (Québec), CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
George A. Pelletier, Jr.
GEORGE A. PELLETIER, JR. CANTOR COLBURN LLP20 CHURCH ST FL 22HARTFORD, CT 06103-1221UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Extended release formulations, compositions and agents, namely, chemical additives and botanical extracts, namely, extracts coming from green plants, red plants, seaweed, micro and macro algae, brown algae and bacteria for use in the manufacture of human and veterinary medicinal products for the treatment of circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases, illnesses, disorders or conditions; extended release formulations, compositions and agents, namely, chemical additives and botanical extracts, namely, extracts coming from green plants, red plants, seaweed, micro and macro algae, brown algae and bacteria for use in the manufacture of human and veterinary medicinal products for the treatment of infertility, diabetes, and/or insulin imbalances; extended release formulations, compositions and agents, namely, chemical additives and botanical extracts, namely, extracts coming from green plants, red plants, seaweed, micro and macro algae, brown algae and bacteria for use in the manufacture of human and veterinary botanical products for the treatment of circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases, illnesses, disorders or conditions; extended release formulations, compositions and agents, namely, chemical additives and botanical extracts, namely, extracts coming from green plants, red plants, seaweed, micro and macro algae, brown algae and bacteria for use in the manufacture of human and veterinary botanical products for the treatment of infertility, diabetes, and/or insulin imbalances | ACTIVE | — |
| 003 | Cosmetic products, namely, nail polish, nail varnish, nail polish remover, nail conditioner, emery paper; pumice stone for personal use; cosmetic dyes, namely, hair dyes; anti-aging creams and serums, suntan lotion, suntan oil, sun tan lotion, sun screen, sun block, after sun lotion, self-tanning and reconstructive preparations in the nature of colorants for the face, namely, skin tanning lotion and cream, skin tanning spray; depilatories; lipstick, lip gloss, lip balm, lip sun screen, eyeliner, mascara, eye shadow, eye brow pencil, face powder, foundation liquid and cream, liquid make up, powder make up, liquid blush, powder blush, make-up removing preparations; make up compacts containing makeup and puff, blusher compacts containing blush and brush, lip stick and lip gloss compacts containing lipstick and lip gloss with applicator; cotton swabs for cosmetic purposes; cotton balls for cosmetic purposes; Tooth and mouth care products, namely, tooth gel, tooth paste, tooth polish, tooth powder, tooth whitener and bleach; and mouthwash; Body care products, namely, essential oil, massage oil, cleansing lotion and cleansing oil, astringents for cosmetic purposes, night cream, anti wrinkle cream and lotion, barrier cream, namely, body cream and mud, mask preparation for treating the skin, bath salts, bubble bath, bath foam, bath oil, bath and shower gel, liquid and bar soap for personal use, body scrub and exfoliant, shaving soap, antiperspirant, talcum powder, body powder, perfume, eau de cologne, deodorant for personal use, perfuming sachets | ACTIVE | — |
| 004 | Biofuels, namely, gaseous, solid and liquid fuel derived from plant and other biomass material | ACTIVE | — |
| 005 | Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention, treatment and alleviation of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the treatment and of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of a symptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic orthrombolytic agents for the treatment of arterial, pulmonary and heart disease and afflictions and to restore arterial and vascular patency in order to prevent loss of tissue, limb and organ function; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely, auto immune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, tumors of the immunological organs; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of irritable bowel disorder, Crohn's disease and ulcerative colitis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis, psoriasis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; and nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals that control the solubility, compressibility and/or flow ability of drugs; oral extended release pharmaceuticals for the treatment of angina and hypertension; rapidly dissolving matrix pharmaceutical preparations to which may be added medicinal active ingredients for the treatment of dermatological, cardiopulmonary, respiratory, neurological, gastrointestinal related diseases and disorders for humans and for veterinary use; Botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; botanical naturopathic pharmaceutical preparations and substances for the cessation of smoking; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of sexually transmitted diseases; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of herpes; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; botanical based anti-depressants; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of a symptomatic left ventricular dysfunction; botanical naturopathic pharmaceutical preparations and substances, namely, fibrinolytic orthrombolytic agents for the treatment of arterial, pulmonary and heart disease and afflictions and to restore arterial and vascular patency in order to prevent loss of tissue, limb and organ function; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely, auto immune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, tumors of the immunological organs; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation namely, pain relief medication and anti inflammatories; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of irritable bowel disorder, Crohn's disease and ulcerative colitis; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; botanical naturopathic pharmaceutical preparations and substances, namely, botanical skin care preparations for use in dermatology, namely, dermatitis, psoriasis and skin pigmentation diseases; botanical naturopathic pharmaceutical preparations and substances for use in oncology; botanical naturopathic pharmaceutical preparations and substances for use in ophthalmology; and botanical based nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; botanical naturopathic pharmaceutical preparation and substance delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals that control the solubility, compressibility and/or flow ability of botanical preparations and substances; oral extended release botanical naturopathic pharmaceutical preparations and substances for the treatment of angina and hypertension; rapidly dissolving matrix botanical and naturopathic pharmaceutical preparations to which may be added botanical active ingredients for the treatment of dermatological, cardiopulmonary, respiratory, neurological, gastrointestinal related diseases and disorders for humans and for veterinary use; Rinse, namely, dandruff shampoo for controlling, preventing and treating dandruff; Cosmeceutical products, namely, general and advanced medicated hair care preparations; bone implants comprising live tissue, cosmetic surgery implants comprising live tissue | ACTIVE | — |
| 010 | Biosensors for the identification and determination of concentration of substances and other parameters of biological interest, namely, biosensors for detecting diseases, biologic indicators and biologic anomalies; Medical devices, namely, medical instruments for use in performing biopsies, diagnosing and treating cardiovascular, dermatological, cardiopulmonary, respiratory, neurological, gastrointestinal diseases and trauma, fractures, and conducting surgery for human and veterinary use; implantable and extra-corporeal medical devices for human and veterinary non-invasive or surgical repair, fixation, support, immobilization or stabilization of trauma, fractures, disease, disorders, conditions and ailments, namely, screws, plates, cerclage wiring, sutures, pacemakers, internal and external drug delivery systems, bone implants composed of artificial materials, stents, cosmetic surgery implants composed of artificial materials, artificial limbs, lenses for surgical implantation and hearing aids; Bone prostheses for human and veterinary use; Tooth and mouth care products, namely, gum stimulators, tongue scrapers, and palette and soft tissue cleaners in the nature of sprayers for cleaning gums and teeth used in dentists' offices during dental procedures | ACTIVE | — |
| 016 | Paper towels, facial tissues | ACTIVE | — |
| 035 | Retail and wholesale store services featuring advanced pharmaceutical products; Retail and wholesale store and consulting services featuring advanced botanical products; retail and wholesale store services featuring advanced biosensors; Retail and wholesale store services featuring advanced biofuels; Retail and wholesale store services featuring advanced cosmeceutical products; Retail and wholesale store services featuring advanced hair care, cosmetic, tooth and mouth care and body care products; and Retail and wholesale store services featuring advanced medical devices | ACTIVE | — |
| 040 | Manufacture of advanced pharmaceutical products to the order and/or specification of others; Manufacture of advanced botanical products to the order and/or specification of others; Manufacture of advanced biosensors to the order and specification of others; Manufacture of advanced biofuels to the order and specification of others; Manufacture of advanced cosmeceutical products to the order and specification of others; Manufacture of advanced hair care, cosmetic, tooth and mouth care and body care products to the order and specification of others; Manufacture of advanced medical devices to the order and specification of others | ACTIVE | — |
| 042 | Research and development in the field of pharmaceuticals; development of pharmaceutical preparations; clinical evaluation and testing of pharmaceutical compounds; research and development in the field of botanical naturopathic and pharmaceutical products; development of botanical naturopathic and pharmaceutical preparations; clinical evaluation and testing of botanical naturopathic and pharmaceutical products; scientific research and development in the field of biosensors; product development in the field of biosensors; Testing of new products for others in the field of biosensors; scientific research and development in the field of biofuels; Product development in the field of biofuels; testing of new products for others in the field of biofuels; scientific research and development in the field of cosmeceutical products; product development in the field of cosmeceutical products; testing of new products for others in the field of cosmeceutical products; scientific research and development in the field of hair care, cosmetic, tooth and mouth care and body care products; product development in the field of hair care, cosmetic, tooth and mouth care and body care products; testing of new products for others in the field of hair care, cosmetic, tooth and mouth care and body care products; scientific research and development in the field of medical devices; product development in the field of medical devices; testing of new products for others in the field of medical devices | ACTIVE | — |
| 045 | Licensing of pharmaceutical compounds; licensing of botanical products; licensing of biosensors; licensing of biofuels; licensing of cosmeceutical products; licensing of hair care, cosmetic, tooth and mouth care and body care products; licensing of medical devices | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PurGenesis Technologies Inc.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 004
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named PURGENESIS TECHNOLOGIES
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 9, 2016 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 9, 2016 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 14, 2015 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jul 14, 2015 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jul 14, 2015 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 8, 2015 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 8, 2015 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 8, 2015 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 10, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 10, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 3, 2014 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 2, 2014 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jul 2, 2014 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jul 2, 2014 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 2, 2014 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 2, 2014 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 2, 2014 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 30, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 30, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 19, 2013 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 26, 2013 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 26, 2013 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 26, 2013 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 20, 2013 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 14, 2012 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 14, 2012 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 14, 2012 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 14, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 14, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 12, 2012 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 10, 2012 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| May 10, 2012 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| May 10, 2012 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Apr 3, 2012 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 3, 2012 | ALIE | ASSIGNED TO LIE | — |
| Sep 29, 2011 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 29, 2011 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 29, 2011 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 19, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 18, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 18, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 30, 2010 | MDSM | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Nov 29, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 26, 2010 | NWAP | NEW APPLICATION ENTERED | — |